RadNet has acquired ultrasound AI vendor See-Mode Technologies, aiming to enhance workflow efficiency and expand its imaging AI offerings.
Key Details
- 1RadNet completed the acquisition of See-Mode Technologies, an AI company focused on breast and thyroid ultrasound analysis.
- 2See-Mode's FDA-cleared thyroid solution is already deployed at some RadNet outpatient centers, showing a 30% reduction in scan times.
- 3Approximately 20 million ultrasound exams for thyroid and breast are performed annually in the US, highlighting a large addressable market.
- 4RadNet plans to integrate See-Mode’s products into its DeepHealth AI portfolio and market them to third parties.
- 5The deal follows earlier acquisitions of iCAD, Quantib, Aidence, and Kheiron by RadNet, further bolstering their AI division.
- 6Financial terms of the acquisition were not disclosed.
Why It Matters
This acquisition demonstrates RadNet's commitment to expanding AI-driven workflow improvements in high-volume, complex ultrasound exams, potentially increasing access and efficiency. The integration of advanced AI solutions is positioned to benefit both clinicians and patients, with commercial implications for the broader radiology AI market.
Source
Radiology Business
Related News
•AuntMinnie
GE HealthCare Acquires icometrix to Bolster MRI Neurology AI
GE HealthCare is acquiring icometrix to expand its AI-powered MRI neuroimaging capabilities and integrate advanced analytics into its global product ecosystem.
•AuntMinnie
Bayer Shuts Down Calantic and Blackford Radiology AI Platforms
Bayer is discontinuing its Calantic Digital Solutions AI platform and ceasing Blackford Analysis services, signaling a major retreat from the radiology AI platform sector.
•AuntMinnie
AI in Breast Imaging Achieves High NPV but Raises Recall Rates
AI systems in breast imaging yield near-perfect negative predictive value but increase recall rates compared to radiologists, particularly for intermediate-risk classifications.